All Perspectives, One Place.
Published loading...Updated

Moderna, facing revenue misses and political headwinds, disappoints Wall Street

Summary by Endpoints News
Moderna tried to assuage investors Thursday that enhanced scrutiny of its vaccines in the US wouldn’t hamper its progress. Ultimately, though, middling execution of the business may have proved to be more impactful on its ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endpoints News broke the news in on Thursday, May 1, 2025.
Sources are mostly out of (0)